Rosalind Advisors, Inc. — 13F holdings

Rosalind Advisors, Inc. reported 35 holdings worth $269M in its 13F filing for Q2 2026, filed August 14, 2026.

Largest positions

1. DCTH DELCATH SYS INC — $41.6M (15.4%)
2. FENC FENNEC PHARMACEUTICALS INC — $34.3M (12.7%)
3. XERS XERIS BIOPHARMA HOLDINGS INC — $23.0M (8.6%)
4. SVRA SAVARA INC — $19.6M (7.3%)
5. VSTM VERASTEM INC — $15.2M (5.7%)
6. XFOR X4 PHARMACEUTICALS INC — $15.0M (5.6%)
7. EYPT EYEPOINT PHARMACEUTICALS INC — $14.1M (5.2%)
8. CYBIN INC — $12.9M (4.8%)
9. VOR VOR BIOPHARMA INC — $11.9M (4.4%)
10. PCVX VAXCYTE INC — $11.6M (4.3%)